STAT+

    China’s rapid ascent is reshaping drug development

    Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. The NIH’s foreign subaward crackdown is scrambling global collaborations, while China’s rapid ascent is reshaping drug development. Meanwhile, Wave Life Sciences sheds half its value on underwhelming obesity results. Also, breaking: I’m adopting a rogue…

    Read More
    China biotech, Novo layoffs, Odyssey fundraising

    China biotech, Novo layoffs, Odyssey fundraising

    Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. The news coming out of D.C. never stops. We get into all of it below. Trump reportedly discussing crackdown on Chinese drugs The Trump administration is considering implementing severe restrictions on drugs from…

    Read More